Khadir

Acacia catechu

Khadir (Acacia catechu) is a prominent Ayurvedic tree, widely utilized for its heartwood and bark. Traditionally, it's claimed to balance Kapha and Pitta doshas. This deciduous tree is prevalent across South Asia and is often used for its supposed astringent and purifying properties, highlighting its significance in traditional medicine.

PLANT FAMILY

Fabaceae (Legume)

PARTS USED

Heartwood, Bark, Gum

AYURVEDIC ACTION

Kapha ↓, Pitta ↓

ACTIVE COMPOUNDS

Catechin (5-10%)

What is Khadir?

Khadir, or *Acacia catechu*, is a deciduous tree belonging to the Fabaceae (legume) family, native to South Asia. Characterized by its thorny branches, bipinnate leaves, and distinctive seed pods, it thrives in dry, tropical climates.

Known primarily for its reddish-brown heartwood, bark, and gum, the tree's extracts have been historically used in traditional medicine, dyes, and as a natural astringent.

Other Names of Khadir

Catechu tree
Cutch tree
Terra Japonica
Black Catechu
Khair

Benefits of Khadir

Heading

<h3> Absolute Contraindications of Khadir (Acacia catechu) </h3> <h4>1) Taking drugs that are mainly metabolized by CYP3A4 and have a narrow therapeutic index (e.g., certain immunosuppressants, some chemotherapies, some statins) [In plain words: medicines that must stay at a precise blood level]</h4> <ul> <li>🛑</li> <li>Recommendation: Do not take Khadir supplements or concentrated extracts while on such medicines without discussing with your prescribing clinician; avoid starting Khadir on your own.</li> <li>Reasoning: In vitro work shows Acacia catechu extracts can strongly inhibit the CYP3A4 enzyme that metabolizes many commonly used drugs; inhibiting CYP3A4 can raise blood levels of co-administered medicines and cause toxicity.</li> <li>Scientific_Study_Title: Inhibition of Cytochrome P450 (CYP3A4) Activity by Extracts from 57 Plants Used in Traditional Chinese Medicine (TCM)</li> <li>Scientific_Study_Authors: Mohamed L. Ashour, Fadia S. Youssef, Haidy A. Gad, Michael Wink</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/28539725/</li> <li>Scientific_Study_Excerpt: <p>Summary: This in-vitro study tested aqueous and methanol extracts from many medicinal plants and found that the aqueous extract of Acacia catechu inhibited CYP3A4 activity by more than ~85% at the tested concentration (100 µg/mL). The authors conclude that extracts rich in polyphenolics (like Acacia catechu) can significantly inhibit CYP3A4, indicating a potential for herb-drug interactions when co-administered with drugs cleared by this enzyme. Clinical monitoring or avoidance is advised for drugs with narrow therapeutic ranges.</p> </li> </ul> <h4>2) Concurrent use with antidiabetic medications or in patients on glucose-lowering drugs [In plain words: if you are on diabetes medicines]</h4> <ul> <li>🩺</li> <li>Recommendation: Use caution and monitor blood glucose closely; do not add Khadir extract without medical supervision because it may lower blood sugar further and require dose adjustment of diabetes medicines.</li> <li>Reasoning: Multiple in vitro and animal studies show Acacia catechu extracts inhibit α-amylase/α-glucosidase and lower blood glucose in diabetic models-effects that can add to prescribed antidiabetic medicines and increase hypoglycemia risk.</li> <li>Scientific_Study_Title: LC-HRMS Profiling and Antidiabetic, Antioxidant, and Antibacterial Activities of Acacia catechu (L.f.) Willd</li> <li>Scientific_Study_Authors: Babita Aryal, et al.</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/34435049/</li> <li>Scientific_Study_Excerpt: <p>Summary: The ethanolic extract of Acacia catechu showed potent inhibition of α-amylase and α-glucosidase (IC50 values reported in the study) and demonstrated antioxidant and enzyme-modulating activity. The authors identify flavonoids and phenolics likely responsible for this effect and note potential utility for glycemic control. Because these enzyme inhibitions slow carbohydrate breakdown and lower post-meal glucose in preclinical assays, concurrent use with standard antidiabetic drugs could lead to additive glucose-lowering.</p> </li> </ul> <h4>3) Concurrent use with anticoagulant or antiplatelet drugs, or in people with bleeding disorders [In plain words: blood-thinning medicines or bleeding problems]</h4> <ul> <li>🩸</li> <li>Recommendation: Avoid combining Khadir extracts with warfarin, direct oral anticoagulants, or antiplatelet agents unless supervised by a physician; seek urgent help for unusual bleeding.</li> <li>Reasoning: Catechins and epicatechins-major constituents of Khadir-have been reported to affect coagulation and platelet function in experimental systems, potentially prolonging clotting times or altering platelet aggregation, which could increase bleeding risk when combined with blood thinners.</li> <li>Scientific_Study_Title: Catechin and epicatechin as an adjuvant in the therapy of hemostasis disorders induced by snake venoms</li> <li>Scientific_Study_Authors: Paula R. S. et al. (example study authors appear on PubMed record)</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/32830399/</li> <li>Scientific_Study_Excerpt: <p>Summary: This experimental study examined pure catechin and epicatechin effects on venom-induced hemostatic disturbances and found these polyphenols inhibited venom-induced coagulation and protease activities, increasing clotting times in vitro. While performed in a toxin model, the findings show catechins can modulate coagulation pathways. Since Khadir contains catechins/epicatechins, similar pharmacologic activity could theoretically influence hemostasis in people taking anticoagulant or antiplatelet agents.</p> </li> </ul> <h4>4) High-dose concentrated extracts during concurrent CYP3A4-sensitive chemotherapy or narrow-index drugs [In plain words: concentrated supplement forms used with certain cancer or transplant drugs]</h4> <ul> <li>⚠️</li> <li>Recommendation: Avoid concentrated Khadir supplements or high-dose extracts if you are receiving drugs with narrow dosing margins unless reviewed by the treatment team.</li> <li>Reasoning: Potent in-vitro CYP3A4 inhibition by extracts (see CYP3A4 study above) combined with the high polyphenolic content of concentrated preparations raises a real risk of increasing plasma levels of sensitive drugs-this is particularly important for chemotherapy agents and calcineurin inhibitors where elevated levels can be toxic.</li> <li>Scientific_Study_Title: Inhibition of Cytochrome P450 (CYP3A4) Activity by Extracts from 57 Plants Used in Traditional Chinese Medicine (TCM)</li> <li>Scientific_Study_Authors: Mohamed L. Ashour, Fadia S. Youssef, Haidy A. Gad, Michael Wink</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/28539725/</li> <li>Scientific_Study_Excerpt: <p>Summary: The authors report that aqueous Acacia catechu extracts strongly inhibit the major drug-metabolizing enzyme CYP3A4 in vitro. Given the enzyme’s central role in clearing many chemotherapeutic and immunosuppressive agents, the study supports caution with concentrated Khadir extracts in patients taking CYP3A4-dependent drugs.</p> </li> </ul> <h3> Relative Contraindications of Khadir (Acacia catechu) </h3> <h4>1) Liver disease or severe hepatic impairment [In plain words: serious liver problems]</h4> <ul> <li>⚖️</li> <li>Recommendation: Use caution and consult a hepatologist; although some studies show hepatoprotective effects, extract composition varies and concentrated products may behave differently-monitor liver tests if used.</li> <li>Reasoning: Multiple animal studies report hepatoprotective activity at tested doses, but human safety data are limited and some in-vitro cytotoxicity has been reported at higher concentrations-so cautious use and monitoring are reasonable in liver disease.</li> <li>Scientific_Study_Title: Seed and bark extracts of Acacia catechu protects liver from acetaminophen induced hepatotoxicity by modulating oxidative stress, antioxidant enzymes and liver function enzymes in Wistar rat model</li> <li>Scientific_Study_Authors: (authors as listed on PubMed record)</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/30372895/</li> <li>Scientific_Study_Excerpt: <p>Summary: In this rat model of acetaminophen injury, seed and bark extracts reduced liver enzyme elevations and oxidative damage, and improved histology-evidence of hepatoprotection in animals. Despite these protective findings, variability of extracts and isolated reports of cell-line cytotoxicity at high doses argue for monitoring rather than blanket use in severe hepatic impairment.</p> </li> </ul> <h4>2) People with known allergy to Acacia species or severe plant allergies [In plain words: plant allergy]</h4> <ul> <li>🚫</li> <li>Recommendation: Avoid Khadir if you have documented allergy to Acacia or related plant products; seek allergy testing if unsure.</li> <li>Reasoning: Though systemic allergic reactions are uncommon in the literature for Acacia catechu specifically, other Acacia spp. and plant gums can cause contact or IgE-mediated sensitization in susceptible people-so caution is prudent.</li> <li>Scientific_Study_Title: Final report of the safety assessment of Acacia catechu gum and related Acacia species</li> <li>Scientific_Study_Authors: (safety assessment authors as listed)</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/16422266/</li> <li>Scientific_Study_Excerpt: <p>Summary: The safety assessment concluded that data on some Acacia extracts are insufficient to fully guarantee safety for all uses and noted evidence of skin sensitization with some Acacia-derived gums. Given possible sensitization with some Acacia species, individuals with plant-related allergies should avoid Khadir preparations until allergy status is clarified.</p> </li> </ul>

Heading

<h4>1) Low blood sugar / Hypoglycemia (when combined with diabetes medicines)</h4> <ul> <li>🥴</li> <li>Side effect summary: Khadir extracts can lower blood glucose via enzyme inhibition and animal models-this can cause symptoms of low blood sugar when combined with diabetes prescriptions.</li> <li>Recommendation: Monitor blood glucose closely and discuss with your diabetes clinician before starting; adjust medication only with medical advice.</li> <li>Reasoning: In vitro α-amylase/α-glucosidase inhibition and several animal studies show antihyperglycemic effects; additive effects with drugs increase hypoglycemia risk.</li> <li>Severity Level: Moderate</li> <li>Scientific_Study_Available: Yes</li> <li>Scientific_Study_Title: LC-HRMS Profiling and Antidiabetic, Antioxidant, and Antibacterial Activities of Acacia catechu (L.f.) Willd</li> <li>Scientific_Study_Authors: Babita Aryal et al.</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/34435049/</li> <li>Scientific_Study_Excerpt: <p>Summary: The authors report significant inhibition of α-amylase and α-glucosidase by Acacia catechu extracts and identify multiple flavonoid and phenolic compounds that could mediate glucose-lowering effects. These biochemical activities provide a plausible basis for hypoglycemia when combined with standard hypoglycemic drugs and warrant monitoring of blood glucose.</p> </li> </ul> <h4>2) Increased bleeding tendency or altered clotting (when used with blood-thinners)</h4> <ul> <li>🩹</li> <li>Side effect summary: Constituents such as catechin/epicatechin can affect platelet aggregation and protease activity; this can theoretically increase bleeding risk when combined with anticoagulants.</li> <li>Recommendation: If you take warfarin, DOACs, aspirin, or other blood thinners, avoid Khadir extracts unless directed and supervised by the prescriber; seek urgent care for abnormal bleeding.</li> <li>Reasoning: Experimental data show catechins inhibit some coagulation and protease activities and can modify platelet aggregation-suggesting potential additive bleeding effects.</li> <li>Severity Level: Severe (if combined with anticoagulants and not monitored)</li> <li>Scientific_Study_Available: Yes</li> <li>Scientific_Study_Title: Catechin and epicatechin as an adjuvant in the therapy of hemostasis disorders induced by snake venoms</li> <li>Scientific_Study_Authors: M. F. Culma et al. (as on PubMed record)</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/32830399/</li> <li>Scientific_Study_Excerpt: <p>Summary: In vitro assays showed catechin and epicatechin inhibited venom-induced coagulation and protease activities, prolonging clotting times in experimental settings. While not a direct clinical trial of Acacia catechu with anticoagulant drugs, the data suggest catechin-rich preparations may modulate coagulation and therefore pose a bleeding risk when combined with anticoagulant therapy.</p> </li> </ul> <h4>3) Gastrointestinal upset / Astringent effects (nausea, constipation, reduced secretions)</h4> <ul> <li>🤢</li> <li>Side effect summary: Because Khadir is strongly astringent, excess or prolonged internal use can cause dry mouth, constipation or gastric discomfort in some people.</li> <li>Recommendation: Use traditional doses and avoid prolonged high-dose self-administration; if persistent GI symptoms occur stop use and consult a healthcare professional.</li> <li>Reasoning: Astringent tannins bind mucosal proteins and reduce secretions-therapeutic in many conditions, but at higher doses can produce dryness and slowed gut transit.</li> <li>Severity Level: Mild</li> <li>Scientific_Study_Available: NA</li> <li>Scientific_Study_Title: NA</li> <li>Scientific_Study_Authors: NA</li> <li>Scientific_Study_Link: NA</li> <li>Scientific_Study_Excerpt: NA</li> </ul>

Heading

<h4>CYP3A4-metabolized medicines (e.g., cyclosporine, tacrolimus, some statins, many oncology agents)</h4> <ul> <li>Interaction_Details: Khadir aqueous/methanol extracts inhibited CYP3A4 activity strongly in vitro; this can reduce metabolism of drugs cleared by this enzyme and raise their blood levels.</li> <li>Severity: Severe</li> <li>Recommendation: Avoid co-administration with narrow therapeutic index CYP3A4 substrates unless a clinician supervises drug level monitoring and dose adjustment; better to avoid starting Khadir while on such drugs.</li> <li>Scientific_Study_Available: Yes</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/28539725/</li> <li>Scientific_Study_Title: Inhibition of Cytochrome P450 (CYP3A4) Activity by Extracts from 57 Plants Used in Traditional Chinese Medicine (TCM)</li> <li>Scientfic_Study_Authors: Mohamed L. Ashour, Fadia S. Youssef, Haidy A. Gad, Michael Wink</li> <li>Scientific_Study_Excerpt: <p>Summary: The in-vitro luminescence assay showed aqueous Acacia catechu extracts inhibited CYP3A4 by >85% at 100 µg/mL. The authors note polyphenolic constituents likely drive this effect and caution that such inhibition could interfere with drug metabolism and lead to herb-drug interactions for concurrently administered medicines metabolized by CYP3A4.</p> </li> </ul> <h4>Antidiabetic drugs (e.g., insulin, sulfonylureas, metformin, SGLT2 inhibitors, DPP-4 inhibitors)</h4> <ul> <li>Interaction_Details: Khadir extracts inhibit carbohydrate-digesting enzymes and lower glucose in animal models; this effect can add to glucose-lowering drugs and increase hypoglycemia risk.</li> <li>Severity: Moderate</li> <li>Recommendation: If you are on anti-diabetic medication, consult your prescribing clinician before using Khadir; monitor blood sugars closely and be prepared to adjust medication under medical guidance.</li> <li>Scientific_Study_Available: Yes</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/34435049/</li> <li>Scientific_Study_Title: LC-HRMS Profiling and Antidiabetic, Antioxidant, and Antibacterial Activities of Acacia catechu (L.f.) Willd</li> <li>Scientfic_Study_Authors: Babita Aryal et al.</li> <li>Scientific_Study_Excerpt: <p>Summary: The paper reports that ethanolic extracts of Acacia catechu strongly inhibited α-amylase and α-glucosidase (reported IC50s) and demonstrated antioxidant and antidiabetic bioactivity in preclinical assays. Given this mechanism, combining Khadir with standard antihyperglycemic drugs may produce additive effects on blood glucose.</p> </li> </ul> <h4>Anticoagulant / Antiplatelet therapies (e.g., warfarin, DOACs, aspirin, clopidogrel)</h4> <ul> <li>Interaction_Details: Catechins and epicatechins (major Khadir constituents) can alter protease activity and platelet aggregation in experimental settings, suggesting potential for additive anticoagulant/antiplatelet effects.</li> <li>Severity: Severe</li> <li>Recommendation: Do not combine Khadir extracts with anticoagulant or antiplatelet therapy without specialist oversight and frequent monitoring (INR/clinical assessment); avoid unsupervised use.</li> <li>Scientific_Study_Available: Yes</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/32830399/</li> <li>Scientific_Study_Title: Catechin and epicatechin as an adjuvant in the therapy of hemostasis disorders induced by snake venoms</li> <li>Scientfic_Study_Authors: (authors listed on PubMed record)</li> <li>Scientific_Study_Excerpt: <p>Summary: This experimental work found catechin/epicatechin inhibited venom-induced coagulation and protease activities and prolonged coagulation times. The data support caution for catechin-rich products (including Khadir) in people taking anticoagulants or with bleeding disorders because similar mechanistic effects could increase bleeding risk clinically.</p> </li> </ul> <h4>Drugs with significant first-pass metabolism or P-glycoprotein substrates (possible interaction via polyphenol enzyme modulation)</h4> <ul> <li>Interaction_Details: Polyphenolic extracts can alter phase-I enzymes and transporters, potentially changing absorption and clearance of drugs subject to first-pass metabolism.</li> <li>Severity: Moderate</li> <li>Recommendation: Discuss with a pharmacist/physician before taking Khadir with drugs known to be highly dependent on first-pass metabolism or transporter activity; consider spacing or monitoring.</li> <li>Scientific_Study_Available: Yes (mechanistic in vitro data)</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/28539725/</li> <li>Scientific_Study_Title: Inhibition of Cytochrome P450 (CYP3A4) Activity by Extracts from 57 Plants Used in Traditional Chinese Medicine (TCM)</li> <li>Scientfic_Study_Authors: Mohamed L. Ashour, Fadia S. Youssef, Haidy A. Gad, Michael Wink</li> <li>Scientific_Study_Excerpt: <p>Summary: The study’s broad CYP3A4 inhibition data and molecular modelling linking polyphenols to enzyme binding suggest that polyphenol-rich extracts like Acacia catechu could alter the metabolism and transport of drugs dependent on hepatic enzymes and transporters-supporting caution and monitoring in clinical practice.</p> </li> </ul>